Choosing a drug development partner in 2026: A practical selection framework
For emerging and mid-sized biopharma companies, selecting a drug development partner is now a strategic decision that can determine whether…
For emerging and mid-sized biopharma companies, selecting a drug development partner is now a strategic decision that can determine whether…
CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…
The J. P. Morgan Healthcare Conference 2026 (JPM 2026) offers an early view of investor sentiment in the healthcare industry…
Improving and accelerating electronic data capture (EDC) setup times in clinical trials can deliver tangible results and valuable efficiencies. …
Induced pluripotent stem cells (iPSCs) offer immense medical potential1. With almost unrivalled levels of versatility, iPSCs can be modified into…
The European Society of Cardiology (ESC) Annual Meeting 2025, held from August 29 to September 1 in Madrid, Spain, showcased…
The World Health Organization (WHO) has drafted a priority pathogen list to direct funding and resources to the areas that…
Data management plays a vital role in the success and reliability of clinical trials by ensuring the integrity, quality and…
In today’s tech-driven landscape, it seems like every software solution in the clinical industry needs to have some AI angle.…
The clinical trial industry has long recognized the importance of standardization in driving efficiency and ensuring data quality. Efforts by…